Wedbush has started coverage on Zura Bio (NASDAQ: ZURA), assigning an “outperform” rating to the stock. The firm set a price target of $15.00 per share, indicating significant potential growth from current levels.
The new coverage report highlights Wedbush’s positive outlook on Zura Bio’s prospects, reflecting confidence in the company’s future performance.
**Why this matters**
Initiation of coverage by a well-known brokerage like Wedbush can attract investor attention and influence market perception. The “outperform” rating and substantial price target suggest that Wedbush expects Zura Bio to deliver strong returns relative to its peers.
Source: NewsData